je.st
news
Public scrutiny of $4 bn Sun Pharma-Ranbaxy Laboratories deal starts
2014-09-04 11:58:29| Chemicals - Topix.net
CCI had asked the Sun Pharma and Ranbaxy on August 27 to make public specific details of their proposed merger. In the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today invited comments from all stakeholders, including general public, on finer details of USD 4-billion merger of Ranbaxy Laboratories Ltd into rival drugmaker Sun Pharmaceutical Industries .
Tags: public
sun
deal
starts
Category:Chemicals